Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases.
Publication/Presentation Date
2-1-2026
Abstract
Proteoglycans (PGs) are specialized cell-surface and secreted proteins teeming with bioactivity. They have been the subject of fascinating research on autophagy, lymphangiogenesis, and neurodegenerative diseases. PG influence on autophagy extends to several disease domains, and their ability to alter autophagic processes has highlighted their suitability as therapeutic targets. PGs also display new functions by evoking protracted autophagy in lymphatic endothelial cells and inhibiting tumor and physiological lymphangiogenesis. The variable degree of PG sulfation and their ability to regulate growth-factor activities in the central nervous system has opened doors into novel therapeutic avenues including Alzheimer's and Parkinson's diseases. This review systematically integrates these diverse qualities of PGs while highlighting future directions towards clinical application.
Volume
36
Issue
2
First Page
100
Last Page
113
ISSN
1879-3088
Published In/Presented At
Pascal, G. J., Kim, S., Xie, C., Mondal, D., & Iozzo, R. V. (2026). Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases. Trends in cell biology, 36(2), 100–113. https://doi.org/10.1016/j.tcb.2025.06.002
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
40645813
Department(s)
Administration and Leadership
Document Type
Article